BRPI0912928A2 - "composto, e, composição isenta de pirogênio" - Google Patents

"composto, e, composição isenta de pirogênio"

Info

Publication number
BRPI0912928A2
BRPI0912928A2 BRPI0912928-6A BRPI0912928A BRPI0912928A2 BR PI0912928 A2 BRPI0912928 A2 BR PI0912928A2 BR PI0912928 A BRPI0912928 A BR PI0912928A BR PI0912928 A2 BRPI0912928 A2 BR PI0912928A2
Authority
BR
Brazil
Prior art keywords
compound
free composition
pyrogen free
pyrogen
composition
Prior art date
Application number
BRPI0912928-6A
Other languages
English (en)
Inventor
Scott Harbeson
Original Assignee
Concert Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Concert Pharmaceuticals Inc filed Critical Concert Pharmaceuticals Inc
Publication of BRPI0912928A2 publication Critical patent/BRPI0912928A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0912928-6A 2008-08-29 2009-08-28 "composto, e, composição isenta de pirogênio" BRPI0912928A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9329308P 2008-08-29 2008-08-29
PCT/US2009/055427 WO2010025407A1 (en) 2008-08-29 2009-08-28 Substituted triazolo-pyridazine derivatives

Publications (1)

Publication Number Publication Date
BRPI0912928A2 true BRPI0912928A2 (pt) 2015-08-04

Family

ID=41721962

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912928-6A BRPI0912928A2 (pt) 2008-08-29 2009-08-28 "composto, e, composição isenta de pirogênio"

Country Status (17)

Country Link
US (4) US8003646B2 (pt)
EP (2) EP2328414B1 (pt)
JP (3) JP5183808B2 (pt)
KR (1) KR20110063479A (pt)
CN (2) CN104098578A (pt)
AU (1) AU2009285533B2 (pt)
BR (1) BRPI0912928A2 (pt)
CA (1) CA2735549A1 (pt)
DK (1) DK2328414T3 (pt)
EA (1) EA020071B1 (pt)
ES (1) ES2451542T3 (pt)
HR (1) HRP20140195T1 (pt)
MX (1) MX2011002278A (pt)
PL (1) PL2328414T3 (pt)
PT (1) PT2328414E (pt)
WO (1) WO2010025407A1 (pt)
ZA (1) ZA201102123B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009285533B2 (en) * 2008-08-29 2014-02-13 Concert Pharmaceuticals Inc. Substituted triazolo-pyridazine derivatives
US20110177468A1 (en) 2008-10-03 2011-07-21 Fabiola Barbosa Ormiga Galvao Method and device for removing metallic fragments and metallic elements from dental root canals
JP2012531419A (ja) * 2009-06-23 2012-12-10 コンサート ファーマシューティカルズ インコーポレイテッド Ｇａｂａ−ａ受容体修飾物質としての重水素修飾されたトリアゾロピリダジン誘導体
US9957271B2 (en) 2011-10-20 2018-05-01 Glaxosmithkline Llc Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
WO2013059589A1 (en) * 2011-10-20 2013-04-25 Sirtris Pharmaceuticals, Inc. Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
JP6126626B2 (ja) 2012-01-11 2017-05-10 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ テトラゾール−５−イル−およびトリアゾール−５−イル−アリール化合物ならびに除草剤としてのそれの使用
WO2013170243A1 (en) 2012-05-11 2013-11-14 Concert Pharmaceuticals, Inc. Form 5 polymorph of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine
WO2013170241A1 (en) 2012-05-11 2013-11-14 Concert Pharmaceuticals, Inc. Polymorphs of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolol[4,3b]pyridazine
EP2847195A1 (en) 2012-05-11 2015-03-18 Concert Pharmaceuticals Inc. Form 2 polymorph of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine
WO2015052178A1 (en) 2013-10-10 2015-04-16 Basf Se 1,2,5-oxadiazole compounds and their use as herbicides
WO2015052173A1 (en) 2013-10-10 2015-04-16 Basf Se Tetrazole and triazole compounds and their use as herbicides
WO2015095549A1 (en) * 2013-12-18 2015-06-25 Concert Pharmaceuticals, Inc. Dosage regimen for gabaa receptor subtype selective drug
KR20160117596A (ko) 2014-02-07 2016-10-10 오스펙스 파마슈티칼스, 인코포레이티드 신규 제약 제제
CN104353078B (zh) * 2014-11-24 2017-10-24 王寿世 一种麻醉用药物组合物
CN104474549A (zh) * 2014-11-24 2015-04-01 王寿世 异丙酚和gabaa受体拮抗剂在制备***物中的用途
US10026332B1 (en) 2017-04-10 2018-07-17 Jasmine Gupta Method to deliver contextual educational information utilizing smart wearables
BR112021018528A2 (pt) * 2019-03-18 2022-02-08 Neurocycle Therapeutics Inc Uso de moduladores do receptor gabaa para tratamento de dor
WO2023205722A1 (en) * 2022-04-20 2023-10-26 Engrail Therapeutics, Inc. Gabaa receptor modulator salts, particles, and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321162D0 (en) * 1993-10-13 1993-12-01 Boots Co Plc Therapeutic agents
BR9507200A (pt) 1994-03-25 1997-09-16 Isotechnika Inc Melhora da eficácia de drogas por deuteração
US6221335B1 (en) 1994-03-25 2001-04-24 Isotechnika, Inc. Method of using deuterated calcium channel blockers
SK9399A3 (en) 1996-07-25 2000-04-10 Merck Sharp & Dohme Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
HUP0100575A3 (en) * 1998-01-21 2003-03-28 Merck Sharp & Dohme Ltd Hoddes Triazolo-pyridazine derivatives as ligands for gaba receptors
US6440710B1 (en) 1998-12-10 2002-08-27 The Scripps Research Institute Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds
AU772947B2 (en) * 1999-01-27 2004-05-13 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
DE60001623T2 (de) 1999-12-03 2003-12-18 Pfizer Prod Inc Sulfamoylheteroarylpyrazolverbindungen zur Verwendung als analgetisches/entzündungshemmendes Mittel
US20020165217A1 (en) * 2001-05-01 2002-11-07 Pfizer Inc. Combination treatment for anxiety and depression
TW200413273A (en) 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
EP1567869B1 (en) * 2002-11-28 2007-08-22 Neurosearch A/S Method for screening for compounds as potential sedatives or anxiolytics
WO2006061428A2 (en) 2004-12-10 2006-06-15 Universität Zürich Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain
WO2007041630A1 (en) 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
US7750168B2 (en) 2006-02-10 2010-07-06 Sigma-Aldrich Co. Stabilized deuteroborane-tetrahydrofuran complex
JO2630B1 (en) 2006-04-13 2012-06-17 نوفارتيس ايه جي Organic compounds
JP2010501572A (ja) * 2006-08-22 2010-01-21 コンサート ファーマシューティカルズ インコーポレイテッド ４−アミノキナゾリン誘導体およびその使用方法
MX2009002398A (es) 2006-09-05 2009-03-16 Schering Corp Combinaciones farmaceuticas para manejo de lipidos y en el tratamiento de aterosclerosis y estatosis hepatica.
US20080242687A1 (en) * 2007-04-02 2008-10-02 Auspex Pharmaceuticals, Inc. Substituted pyrimidines
AU2009285533B2 (en) * 2008-08-29 2014-02-13 Concert Pharmaceuticals Inc. Substituted triazolo-pyridazine derivatives

Also Published As

Publication number Publication date
US20120004236A1 (en) 2012-01-05
PT2328414E (pt) 2014-03-17
AU2009285533B2 (en) 2014-02-13
EA201100409A1 (ru) 2011-10-31
CA2735549A1 (en) 2010-03-04
EP2328414A1 (en) 2011-06-08
EP2328414B1 (en) 2013-12-11
EP2716158A1 (en) 2014-04-09
DK2328414T3 (en) 2014-03-10
CN102176826A (zh) 2011-09-07
US20130225590A1 (en) 2013-08-29
JP2013100322A (ja) 2013-05-23
CN104098578A (zh) 2014-10-15
JP5373982B2 (ja) 2013-12-18
HRP20140195T1 (hr) 2014-04-11
JP5183808B2 (ja) 2013-04-17
KR20110063479A (ko) 2011-06-10
ZA201102123B (en) 2011-12-28
AU2009285533A2 (en) 2011-04-21
US8399467B2 (en) 2013-03-19
JP2012501346A (ja) 2012-01-19
CN102176826B (zh) 2014-08-20
JP2014058518A (ja) 2014-04-03
MX2011002278A (es) 2011-04-14
US20100056529A1 (en) 2010-03-04
EP2328414A4 (en) 2011-11-16
US20150111895A1 (en) 2015-04-23
PL2328414T3 (pl) 2014-05-30
ES2451542T3 (es) 2014-03-27
WO2010025407A1 (en) 2010-03-04
AU2009285533A1 (en) 2010-03-04
US8003646B2 (en) 2011-08-23
US8921366B2 (en) 2014-12-30
EA020071B1 (ru) 2014-08-29

Similar Documents

Publication Publication Date Title
BRPI0912928A2 (pt) "composto, e, composição isenta de pirogênio"
LTPA2018014I1 (lt) Farmacinė kompozicija 514
BRPI0913806A2 (pt) "composição"
BRPI0916123A2 (pt) "composição de xampu concentrada"
BRPI0910229A2 (pt) Tetramatos de 4';4'-dioxaspiro espirociclicamente substituídos
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0716325A2 (pt) Composição antimicrobianas
FR2899479B1 (fr) Composition cicatrisante
BRPI0810928A2 (pt) "composição farmacêutica"
BRPI0914375A2 (pt) ''composições antiperspirantes''
BRPI0719626A2 (pt) '' composto ''
BRPI0922904A2 (pt) "compostos"
BRPI0923047A2 (pt) "conjugados de proteínas-oligossacarídeos".
BRPI0716458A2 (pt) Composição de vulcanizado
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
BRPI0819383A2 (pt) "composição de limpeza"
BRPI0716046A2 (pt) composiÇÕes de nanopartÍcula.
BRPI0914383A2 (pt) "composição de shampoo condicionador"
BRPI0914503A2 (pt) "composição de shampoo concentrado"
BRPI0914063A2 (pt) composição de xampu concentrado
BRPI0814748A2 (pt) Compostos de alditóis substituídos, composições e métodos
BRPI0715173A2 (pt) Composições de perfume
ATE426005T1 (de) Verbesserte beschichtungszusammensetzung
BRPI0718141A2 (pt) Composições de frangrâncias

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]